The Proteasome Inhibitor Bortezomib Maintains Osteocyte Viability in Multiple Myeloma Patients by Reducing Both Apoptosis and Autophagy: A New Function for Proteasome Inhibitors

Overview of attention for article published in Journal of Bone & Mineral Research, November 2015

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 3 X users

Citations

dimensions_citation: 55 Dimensions

Readers on

mendeley: 30 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 5,760 followers.

RT @Osteoporose_NL: #Proteasome_inhibitor maintains #osteocyte viability in multiple #myeloma by ↓ apoptosis and autophagy https://t.co/Ns9…

Reply Repost Favourite

#Proteasome_inhibitor maintains #osteocyte viability in multiple #myeloma by ↓ apoptosis and autophagy https://t.co/Ns9Laq7ErF

Reply Repost Favourite

The Proteasome Inhibitor, Bortezomib, Maintains Osteocyte Viability in Multiple Myeloma… https://t.co/VRUon7DBPU https://t.co/wcypQh9pQ8

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.